FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

2046011000036108: dolasetron (AU substance)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
175513011000036111 dolasetron en Synonym Active Case sensitive Australian Medicines Terminology module
175514011000036113 dolasetron (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
dolasetron Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Anzemet 100 mg/5 mL injection, 5 mL ampoule has intended active ingredient True dolasetron Inferred relationship Some 2134947165
dolasetron has intended active ingredient True dolasetron Inferred relationship Some 1
dolasetron mesilate monohydrate 25 mg/1.25 mL injection, ampoule has intended active ingredient True dolasetron Inferred relationship Some 1510179951
dolasetron mesilate monohydrate 200 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 831524755
dolasetron mesilate monohydrate 100 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 21468131
dolasetron mesilate monohydrate 25 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 588154165
dolasetron mesilate monohydrate 12.5 mg/0.625 mL injection, ampoule has intended active ingredient True dolasetron Inferred relationship Some 1019164981
dolasetron mesilate monohydrate 200 mg/10 mL injection, ampoule has intended active ingredient True dolasetron Inferred relationship Some 1810913201
dolasetron mesilate monohydrate 100 mg/5 mL injection, ampoule has intended active ingredient True dolasetron Inferred relationship Some 1838778383
dolasetron mesilate monohydrate 50 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 1667082187
dolasetron mesilate monohydrate 50 mg/2.5 mL injection, ampoule has intended active ingredient True dolasetron Inferred relationship Some 745056401
dolasetron mesilate monohydrate is modification of True dolasetron Inferred relationship Some
Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule has intended active ingredient True dolasetron Inferred relationship Some 983375835
Anzemet 200 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 927708899
Anzemet 25 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 733089961
Anzemet 25 mg/1.25 mL injection, 1.25 mL ampoule has intended active ingredient True dolasetron Inferred relationship Some 1221413141
Anzemet 50 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 654014627
Anzemet 50 mg/2.5 mL injection, 2.5 mL ampoule has intended active ingredient True dolasetron Inferred relationship Some 517584553
Anzemet 200 mg/10 mL injection, 10 mL ampoule has intended active ingredient True dolasetron Inferred relationship Some 489669075
Anzemet 100 mg tablet has intended active ingredient True dolasetron Inferred relationship Some 1496210223
dolasetron mesilate monohydrate 12.5 mg/0.625 mL injection, vial has intended active ingredient True dolasetron Inferred relationship Some 787290549
Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial has intended active ingredient True dolasetron Inferred relationship Some 2086457811

This concept is not in any reference sets

Back to Start